<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN"
  "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         article-type="original-research-article">

  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">BJAR</journal-id>
      <journal-title-group>
        <journal-title>British Journal of Advanced Research</journal-title>
        <abbrev-journal-title>BJAR</abbrev-journal-title>
      </journal-title-group>
            <issn pub-type="epub">3153-709X</issn>
            <publisher>
        <publisher-name>Ivory and Finch Publishers</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="doi">10.68263/BJAR-DPXR79XY</article-id>
      <article-id pub-id-type="publisher-id">BJAR_SEP_26_021</article-id>

      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research Article</subject>
        </subj-group>
      </article-categories>

      <title-group>
        <article-title>Factors Affecting Drug Adherence Among Adolescents Living With HIV/AIDS at the Federal Medical Centre, Ido-Ekiti, Ekiti State, Nigeria: A Descriptive Cross-Sectional Study</article-title>
      </title-group>

      <contrib-group>
        <contrib contrib-type="author">
          <name>
                        <surname>Oluwafemi Awosemusi</surname>
            <given-names>Akinwaleoluwa</given-names>
          </name>
                    <aff>Department of Public Health, Faculty of Basic Medical Sciences, Adeleke University, Ede, Osun State, Nigeria</aff>
          <email>duchessbookey@gmail.com</email>
        </contrib>
                                          <contrib contrib-type="author">
              <name>
                                <surname>Oyerinde</surname>
                <given-names>Oyesegun</given-names>
              </name>
                                          <aff>Adeleke University, Ede, Osun State</aff>
                          </contrib>
                                              <contrib contrib-type="author">
              <name>
                                <surname>Omodele</surname>
                <given-names>Morenike</given-names>
              </name>
                                          <aff>Adeleke University, Ede, Osun State</aff>
                          </contrib>
                                    </contrib-group>

            <pub-date pub-type="epub">
        <day>10</day>
        <month>10</month>
        <year>2026</year>
      </pub-date>
      <volume>1</volume>
      <issue>4</issue>
      
      
            <self-uri xlink:href="https://doi.org/10.68263/BJAR-DPXR79XY"/>
      
      <abstract>
        <p>Background: Adolescents living with HIV face unique challenges that affect health outcomes, including adherence to antiretroviral therapy (ART). Suboptimal adherence contributes to viral resistance, treatment failure, and increased morbidity. This study examined the promotive and inhibitory factors affecting drug adherence among adolescents living with HIV at the Federal Medical Centre (FMC), Ido-Ekiti, Ekiti State, Nigeria.
 
Methods: A descriptive cross-sectional study was conducted among 272 adolescents living with HIV at FMC Ido-Ekiti. Participants were selected by systematic sampling and interviewed using a pre-tested, structured questionnaire covering sociodemographic characteristics, HIV knowledge, and predisposing and reinforcing adherence factors. Data were analysed using IBM SPSS Statistics v27.0. Chi-square tests determined associations between categorical variables (significance: p &lt; 0.05).
 
Results: The mean age was 16.4 ± 2 years; 51.1% were female and 85.7% were single. Health facilities were the most common information source (55.1%) and 73.2% had good HIV knowledge. Only 50.7% reported easy adherence to medication. The most prominent barrier was lack of transportation for medication refills (30.5%). Factors significantly associated with HIV knowledge included family type (p = 0.002), education level (p &lt; 0.001), and years since diagnosis (p &lt; 0.001). Factors significantly associated with adherence included marital status (p = 0.002), family type (p &lt; 0.001), years since diagnosis (p &lt; 0.001), family APGAR score (p &lt; 0.001), and HIV knowledge level (p &lt; 0.001).
 
Conclusion: Despite generally high HIV knowledge, only half of the adolescents adhered adequately to ART. Transportation barriers, family type, and limited social support were key impediments. Family support and regular healthcare provider engagement promoted adherence. Targeted transport subsidies, community-based medication delivery, and strengthened social support networks are recommended.</p>
      </abstract>

            <kwd-group kwd-group-type="author-keywords">
                <kwd>Antiretroviral Therapy; Adolescents; Drug Adherence; Hiv/Aids; Nigeria; Medication Adherence</kwd>
              </kwd-group>
      
      <history>
        <date date-type="received">
          <day>15</day>
          <month>09</month>
          <year>2026</year>
        </date>
                <date date-type="accepted">
          <day>17</day>
          <month>09</month>
          <year>2026</year>
        </date>
              </history>

      <permissions>
        <copyright-statement>Copyright &copy; 2026 by the authors</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.</license-p>
        </license>
      </permissions>

    </article-meta>
  </front>

    <back>
    <ref-list>
      <title>References</title>
                      <ref id="ref-1">
          <mixed-citation>1. World Health Organization. HIV/AIDS: Key facts [Internet]. Geneva: WHO; 2023 [cited 2024]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids</mixed-citation>
        </ref>
                              <ref id="ref-2">
          <mixed-citation>2. Adeniji A, Ogubuike G. [Full title to be confirmed by authors]. [Journal]. 2024. [Details to be completed].</mixed-citation>
        </ref>
                              <ref id="ref-3">
          <mixed-citation>3. Oluwole EO, Ibidapo DO, Akintan PE, Adegoke AB, Shogbamimu YO. Medication adherence, barriers to adherence and treatment satisfaction with antiretroviral therapy among adolescents living with HIV in Lagos, Nigeria. Ann Health Res. 2023;9(3):222–37. doi:10.30442/ahr.0903-06-208</mixed-citation>
        </ref>
                              <ref id="ref-4">
          <mixed-citation>4. Asaolu OS, Agbede C. Factors influencing medication adherence among young people living with HIV in Niger State, Nigeria. Open J Med Res. 2022;3(1):12–9.</mixed-citation>
        </ref>
                              <ref id="ref-5">
          <mixed-citation>5. Okonji EF, Mukumbang FC, Orth Z, Vickerman-Delport SA, Van Wyk B. Psychosocial support interventions for improved adherence and retention in ART care for young people living with HIV (10–24 years): a scoping review. BMC Public Health. 2020;20(1):1198. doi:10.1186/s12889-020-09717-y</mixed-citation>
        </ref>
                              <ref id="ref-6">
          <mixed-citation>6. Nigeria HIV/AIDS Indicator and Impact Survey. National summary sheet. Abuja: Federal Ministry of Health; 2019.</mixed-citation>
        </ref>
                              <ref id="ref-7">
          <mixed-citation>7. Federal Ministry of Health – National AIDS and STIs Control Programme. National guidelines for HIV prevention, treatment and care. Abuja: FMH-NASCP; 2020. Available from: https://nascp.gov.ng/resources/get_resource_doc/17</mixed-citation>
        </ref>
                              <ref id="ref-8">
          <mixed-citation>8. Vincent N, Musa BM, Femi O. [Full title to be confirmed by authors]. [Journal]. 2021. [Details to be confirmed].</mixed-citation>
        </ref>
                              <ref id="ref-9">
          <mixed-citation>9. Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA. 2015;314(18):1966–7. doi:10.1001/jama.2015.15281</mixed-citation>
        </ref>
                              <ref id="ref-10">
          <mixed-citation>10. Aderemi-Williams RI, Razaq AR, Abah IO, Opanuga OO, Akanmu AS. Adolescents and young adults knowledge, adherence and experiences while on antiretroviral therapy in a tertiary hospital in Lagos, Nigeria: a mixed-method study. J Int Assoc Provid AIDS Care. 2021;20. doi:10.1177/23259582211062754</mixed-citation>
        </ref>
                              <ref id="ref-11">
          <mixed-citation>11. Anyaike C, Atoyebi OA, Musa OI, Bolarinwa OA, Durowade KA, Ogundiran A, et al. Adherence to combined antiretroviral therapy (cART) among people living with HIV/AIDS in a tertiary hospital in Ilorin, Nigeria. Pan Afr Med J. 2019;32:10. doi:10.11604/pamj.2019.32.10.7508</mixed-citation>
        </ref>
                              <ref id="ref-12">
          <mixed-citation>12. Ojo JO, Ipinnimo TM, Afolayan AC, Adewoye KR, Erinomo OO, Ajayi PO, et al. Factors associated with willingness to use mHealth interventions for medication adherence among people living with HIV attending a tertiary hospital in sub-Saharan Africa. PLoS ONE. 2024;19(8):e0309119. doi:10.1371/journal.pone.0309119</mixed-citation>
        </ref>
                              <ref id="ref-13">
          <mixed-citation>13. Badru T, Mwaisaka J, Khamofu H, Agbakwuru C, Adedokun O, Pandey SR, et al. HIV comprehensive knowledge and prevalence among young adolescents in Nigeria: evidence from Akwa Ibom AIDS indicator survey, 2017. BMC Public Health. 2020;20(1):116. doi:10.1186/s12889-019-7890-y</mixed-citation>
        </ref>
                              <ref id="ref-14">
          <mixed-citation>14. Kawuki J, Gatasi G, Sserwanja Q, Mukunya D, Musaba MW. Comprehensive knowledge about HIV/AIDS and associated factors among adolescent girls in Rwanda: a nationwide cross-sectional study. BMC Infect Dis. 2023;23(1):176. doi:10.1186/s12879-023-08187-y</mixed-citation>
        </ref>
                              <ref id="ref-15">
          <mixed-citation>15. Oniye A, Olaitan O, Olawuyi B, Obiyemi O, Talabi A, Oyerinde OO. Knowledge of transmission patterns of HIV/AIDS and the place of health counselling among students of tertiary institutions in Kwara State, Nigeria. KIU J Soc Sci. 2017;3(2).</mixed-citation>
        </ref>
                              <ref id="ref-16">
          <mixed-citation>16. Laurenzi CA, Skeen S, Gordon S, Akin-Olugbade O, Abrahams N, Bradshaw M, et al. Preventing mental health conditions in adolescents living with HIV: an urgent need for evidence. J Int AIDS Soc. 2020;23(S5):e25556. doi:10.1002/jia2.25556</mixed-citation>
        </ref>
                              <ref id="ref-17">
          <mixed-citation>17. Johnson-Peretz J, Onyango A, Gutin SA, Balzer L, Akatukwasa C, Owino L, et al. Clinical implications of HIV treatment and prevention for polygamous families in Kenya and Uganda. J Int Assoc Provid AIDS Care. 2024;23. doi:10.1177/23259582241255171</mixed-citation>
        </ref>
                              <ref id="ref-18">
          <mixed-citation>18. Nabunya P, Bahar OS, Chen B, Dvalishvili D, Damulira C, Ssewamala FM. The role of family factors in antiretroviral therapy (ART) adherence self-efficacy among HIV-infected adolescents in southern Uganda. BMC Public Health. 2020;20(1):265. doi:10.1186/s12889-020-8361-1</mixed-citation>
        </ref>
                  </ref-list>
  </back>
  
</article>
